Market Overview:
The global NGS in agrigenomics market is expected to grow at a CAGR of 16.5% during the forecast period from 2018 to 2030. The growth of this market can be attributed to the increasing demand for precision agriculture, rising investments in R&D by agricultural biotechnology companies, and growing awareness about the benefits of using NGS technology for plant breeding and crop improvement. Based on type, the global NGS in agrigenomics market can be segmented into NovaSeq, NextSeq, Sequel, and nanopore sequencing systems. The NovaSeq sequencing system is expected to account for the largest share of this market in 2018 owing to its high throughput capacity and low cost per base pair sequencing. Based on application, the global NGS in agrigenomics market can be divided into academic institutes & research centers; hospitals & clinics; pharmaceutical & biotechnology companies; and other end users such as seed banks & gene banks. The academic institutes & research centers segment is projected to grow at the highest CAGR during the forecast period owing to rising funding from government agencies and private organizations for agricultural R&D activities.
Product Definition:
NGS In Agrigenomics is the Next Generation Sequencing technology used in the field of agriculture and genomics. It helps in deciphering the genetic code of plants and animals to understand their biology and improve their production.
NovaSeq:
NovaSeq is a new generation sequencing (NGS) based technology that facilitates the efficient and rapid isolation of nucleic acids from genomic DNA, RNA samples. NovaSeq has been developed by Illumina in order to meet the growing demand for high-throughput sequencing applications in agrigenomics. NovaSeq allows users to sequence up to 100x more samples than other NGS platforms with similar output quality.
NextSeq:
NextSeq is a next-generation sequencing (NGS) system that delivers high-throughput, cost-effective and quality DNA sequencing. It is developed by Illumina, Inc. for the analysis of low input samples such as genomic DNA. NextSeq has been designed to be used in conjunction with Illumina’s BaseSpace platform which provides high capacity storage and distribution of raw data generated during NGS runs along with easy access to data from any location through the internet.
Application Insights:
Based on application, the global market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical and biotechnology companies and others. The academic institutes & research centers segment dominated the market in 2017 owing to increasing government funding for genomics-based studies at universities. Moreover, an increase in R&D activities by various companies including Illumina has fueled product launches which are used by most of the researchers across the globe.
Hospitals and clinics are expected to be one of fastest growing segments over forecast period due to introduction of new products with enhanced performance such as NextSeq X Sequencing System from Illumina (San Diego California) which enables rapid sequencing up to 10x faster than other systems while occupying half the memory space. This system is ideal for clinicians working within a hospital or clinical setting where multiple samples need to be sequenced at a time without any additional lab work required post sample processing.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of agribusiness companies, which are engaged in R&D activities for developing advanced varieties and raising productivity levels. The region is expected to maintain its dominance over the forecast period as well owing to increasing government funding for agricultural-related research projects.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising awareness among farmers regarding modern technologies such as NGS and QTL analysis that help them improve their yield levels and profits from their crops/farming activities. Moreover, countries such as China, India, Japan have a huge population base with growing disposable income levels that will fuel demand further over next eight years or so till 2030 AD (Year Of Farm).
Growth Factors:
- Increasing demand for food due to population growth
- Rising awareness about the benefits of using NGS in agrigenomics
- Technological advancements in sequencing platforms and bioinformatics tools
- Growing investments in research and development for NGS-based agrigenomics applications
- Proliferation of genomics data sharing initiatives
Scope Of The Report
Report Attributes
Report Details
Report Title
NGS In Agrigenomics Market Research Report
By Type
NovaSeq, NextSeq, Sequel, Nanopore
By Application
Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others
By Companies
Illumina, Agilent Technologies, Ontario Genomics, Genome Atlantic, LGC, BGI, Neogen, NuGen Technologies, Eurofins Genomics, Arbor Biosciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
215
Number of Tables & Figures
151
Customization Available
Yes, the report can be customized as per your need.
Global NGS In Agrigenomics Market Report Segments:
The global NGS In Agrigenomics market is segmented on the basis of:
Types
NovaSeq, NextSeq, Sequel, Nanopore
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Illumina
- Agilent Technologies
- Ontario Genomics
- Genome Atlantic
- LGC
- BGI
- Neogen
- NuGen Technologies
- Eurofins Genomics
- Arbor Biosciences
Highlights of The NGS In Agrigenomics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- NovaSeq
- NextSeq
- Sequel
- Nanopore
- By Application:
- Academic Institutes & Research Centers
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the NGS In Agrigenomics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
NGS is a powerful tool for exploring the genetic diversity of crops and their associated ecosystems. By sequencing the genomes of different plants, scientists can identify which genes are responsible for specific traits, such as resistance to pests or drought tolerance. This information can then be used to improve crop production in future generations.
Some of the major companies in the ngs in agrigenomics market are Illumina, Agilent Technologies, Ontario Genomics, Genome Atlantic, LGC, BGI, Neogen, NuGen Technologies, Eurofins Genomics, Arbor Biosciences.
The ngs in agrigenomics market is expected to register a CAGR of 16.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 NGS In Agrigenomics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 NGS In Agrigenomics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 NGS In Agrigenomics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the NGS In Agrigenomics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global NGS In Agrigenomics Market Size & Forecast, 2020-2028
4.5.1 NGS In Agrigenomics Market Size and Y-o-Y Growth
4.5.2 NGS In Agrigenomics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 NovaSeq
5.2.2 NextSeq
5.2.3 Sequel
5.2.4 Nanopore
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Academic Institutes & Research Centers
6.2.2 Hospitals & Clinics
6.2.3 Pharmaceutical & Biotechnology Companies
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global NGS In Agrigenomics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 NGS In Agrigenomics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 NovaSeq
9.6.2 NextSeq
9.6.3 Sequel
9.6.4 Nanopore
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Academic Institutes & Research Centers
9.10.2 Hospitals & Clinics
9.10.3 Pharmaceutical & Biotechnology Companies
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 NovaSeq
10.6.2 NextSeq
10.6.3 Sequel
10.6.4 Nanopore
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Academic Institutes & Research Centers
10.10.2 Hospitals & Clinics
10.10.3 Pharmaceutical & Biotechnology Companies
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 NovaSeq
11.6.2 NextSeq
11.6.3 Sequel
11.6.4 Nanopore
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Academic Institutes & Research Centers
11.10.2 Hospitals & Clinics
11.10.3 Pharmaceutical & Biotechnology Companies
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 NovaSeq
12.6.2 NextSeq
12.6.3 Sequel
12.6.4 Nanopore
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Academic Institutes & Research Centers
12.10.2 Hospitals & Clinics
12.10.3 Pharmaceutical & Biotechnology Companies
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 NovaSeq
13.6.2 NextSeq
13.6.3 Sequel
13.6.4 Nanopore
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Academic Institutes & Research Centers
13.10.2 Hospitals & Clinics
13.10.3 Pharmaceutical & Biotechnology Companies
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 NGS In Agrigenomics Market: Competitive Dashboard
14.2 Global NGS In Agrigenomics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Illumina
14.3.2 Agilent Technologies
14.3.3 Ontario Genomics
14.3.4 Genome Atlantic
14.3.5 LGC
14.3.6 BGI
14.3.7 Neogen
14.3.8 NuGen Technologies
14.3.9 Eurofins Genomics
14.3.10 Arbor Biosciences
